Jaide provides an AI‑powered clinical assistant that automates note‑taking, dictation, and medical report generation, helping physicians reclaim up to four hours per week for patient care. The platform also offers interpretable predictive models for prostate and lung cancer to support personalized oncology decisions, and it operates via a secure, GDPR‑compliant cloud service with one‑click integration into existing workflows.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare providers spend significant time on clinical documentation and generating medical reports, reducing the time available for direct patient care. Additionally, oncologists lack accessible predictive tools to personalize treatment strategies for cancer patients.
Solution
Jaide offers an AI-powered clinical assistant that automates note‑taking, dictation, and medical report generation, allowing clinicians to reclaim up to four hours per week for patient interaction. The platform integrates a one‑click AI consultation interface and supports immediate deployment without software installation. For oncology, Jaide provides interpretable predictive models—such as an 80% auROC model for 10‑year prostate cancer outcomes and a multimodal model for early detection of non‑response to EGFR‑targeted therapies in lung cancer. All data are stored in GDPR‑compliant HDS facilities within the EU, ensuring security and privacy. The service is delivered via subscription plans that scale from basic dictation to advanced oncology‑focused features, enabling flexible adoption based on clinical needs.
Target Audience
Primary users are physicians, radiologists, and oncology specialists in hospitals or outpatient clinics who need efficient documentation and data‑driven decision support.
Features
- Automated clinical documentation and dictation using large language models, reducing manual note‑taking effort
- One‑click AI consultation launch with ambient AI assistance during patient visits
- Interoperable output compatible with existing EHR systems via secure data exchange
- Predictive oncology models: 10‑year prostate cancer progression (auROC 80%) and early non‑response detection for EGFR+ lung cancer
- GDPR‑compliant HDS data storage in the EU, ensuring patient privacy and regulatory adherence
- Tiered subscription options (Free trial, Dictation‑only, Pro, Premium) allowing scalable feature access
- Secure, cloud‑based architecture with no local software installation required